UNSPSC 51333706: Citicoline sodium

This classification denotes the sodium form of a nootropic agent with the molecular formula C14H25N4O11P2.H+, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 536BQ2JVC7, chemically known as cytidine 5-(trihydrogen pyrophosphate), monoester with choline hydroxide, inner salt but more generally known as citicoline, which bears US NIH Compound Identifier 291. European Medicines Agency schedules Citicoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07489MIG.

UNSPSC 51333706 Citicoline sodium is a Commodity code ostensibly for a specific pharmaceutical ingredient, but recent state and local procurement activity tagged under this code shows minimal alignment with the code's nominal scope. The three most recent opportunities involve naloxone and drug deactivation systems procurement (Seminole County, Florida), a therapeutic pharmacy initiative direct-to-manufacturer prescription program exploration (Texas Health and Human Services Commission), and a multistate cooperative pharmaceutical and over-the-counter product contract (Minnesota Multistate Cooperative Purchasing Alliance). These solicitations reflect broader pharmaceutical supply and managed-care program development rather than procurement of citicoline sodium specifically, suggesting either systematic code misclassification in state procurement databases or use of the code as a catch-all for pharmaceutical commodity activity.

Issuing bodies in recent activity span county health departments, state health agencies, and multistate cooperative purchasing vehicles. The Minnesota Multistate Cooperative Purchasing Alliance administered by the Minnesota Department of Administration's Office of State Procurement has driven the most recent high-profile activity, with an RFP due March 26, 2026 for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC). Seminole County, Florida released an IFB on June 30, 2026 (response deadline July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, while the Texas Health and Human Services Commission posted an RFI on April 3, 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The code shows sparse and geographically dispersed recent activity; no single jurisdiction or region dominates procurement under this classification.